This familial breast cancer guideline doesn’t change anything for us. Our role is to risk assess women and refer on to the genetics services if they may be at high risk. NICE do say that this shouldn’t be screening, but a response to a concerned woman, or if there seems to be a significant history on doing a pill or HRT check.
Also of interest is that ‘TP53’ is now tested for, alongside BRCA1 and 2
How to do a familial breast cancer risk assessment
This hasn’t changed from the last guideline. There was a handy flowchart in the last guideline, which I keep printed out to use.